A detailed history of Dimensional Fund Advisors LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 166,147 shares of DYN stock, worth $4.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,147
Previous 171,185 2.94%
Holding current value
$4.34 Million
Previous $6.04 Million 1.21%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$31.94 - $47.04 $160,913 - $236,987
-5,038 Reduced 2.94%
166,147 $5.97 Million
Q2 2024

Aug 09, 2024

SELL
$23.65 - $35.63 $3.68 Million - $5.54 Million
-155,444 Reduced 47.59%
171,185 $6.04 Million
Q1 2024

May 10, 2024

SELL
$13.06 - $29.18 $6.25 Million - $14 Million
-478,922 Reduced 59.45%
326,629 $9.27 Million
Q4 2023

Feb 07, 2024

SELL
$6.62 - $13.64 $911,289 - $1.88 Million
-137,657 Reduced 14.59%
805,551 $10.7 Million
Q3 2023

Nov 09, 2023

BUY
$8.6 - $12.18 $1.23 Million - $1.74 Million
142,983 Added 17.87%
943,208 $8.45 Million
Q2 2023

Aug 09, 2023

BUY
$8.53 - $14.28 $1.19 Million - $1.99 Million
139,595 Added 21.13%
800,225 $9 Million
Q1 2023

May 12, 2023

BUY
$10.88 - $15.0 $2.23 Million - $3.07 Million
204,642 Added 44.88%
660,630 $7.61 Million
Q4 2022

Feb 09, 2023

BUY
$9.37 - $13.8 $1.58 Million - $2.32 Million
168,387 Added 58.55%
455,988 $5.28 Million
Q3 2022

Nov 10, 2022

BUY
$7.2 - $15.17 $1.47 Million - $3.11 Million
204,811 Added 247.39%
287,601 $3.65 Million
Q2 2022

Aug 12, 2022

BUY
$4.36 - $10.5 $141,752 - $341,376
32,512 Added 64.66%
82,790 $568,000
Q1 2022

May 13, 2022

BUY
$6.52 - $12.27 $93,014 - $175,043
14,266 Added 39.61%
50,278 $484,000
Q4 2021

Feb 09, 2022

BUY
$11.89 - $16.07 $428,182 - $578,712
36,012 New
36,012 $428,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.35B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.